OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
8.64
-0.10 (-1.14%)
At close: Mar 28, 2025, 4:00 PM
8.66
+0.02 (0.21%)
After-hours: Mar 28, 2025, 7:56 PM EDT
OptimizeRx Employees
As of December 31, 2024, OptimizeRx had 129 total employees, including 128 full-time and 1 part-time employees. The number of employees decreased by 7 or -5.15% compared to the previous year.
Employees
129
Change (1Y)
-7
Growth (1Y)
-5.15%
Revenue / Employee
$714,163
Profits / Employee
-$155,891
Market Cap
159.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
OPRX News
- 18 days ago - OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
- 18 days ago - OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 19 days ago - OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations - GlobeNewsWire
- 20 days ago - OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer - GlobeNewsWire
- 4 weeks ago - OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET - GlobeNewsWire
- 3 months ago - OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO - GlobeNewsWire
- 4 months ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire